1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
Artemis Therapeutics Inc.

Artemis Therapeutics Inc.

ATMS
Artemis Therapeutics Inc.US flagOther OTC
0.50
USD
-1.39
- -
55.79MMarket Cap
Artemis Therapeutics Inc.
ATMS
(Other OTC)

Recent

price

0.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Similar Companies
TKB Critical Technologies 1 (USCT)
Warburg Pincus Capital Corporation I-A (WPCA)
Primavera Capital Acquisition Corporation (PV)
Inspired Builders, Inc. (ISRB)
Berenson Acquisition Corp. I (BACA-UN)
Mijem Newcomm Tech Inc. (MJEM.CN)
Business
Artemis Therapeutics Inc. primarily operates through its wholly owned subsidiary, which focuses on the development and distribution of supplements and skincare products. These offerings are formulated with natural components, including Manuka honey and bee venom. The company's business activities shifted significantly following a reverse merger transaction in June 2022, prior to which it was classified as a shell company. Previously, its efforts were directed toward creating treatments for severe infectious diseases. Headquartered in New York, New York, the firm's shares are quoted on the OTC Pink Market under the symbol ATMS.